LENSAR Inc (LNSR) is a Healthcare · Medical Devices company listed on NASDAQ. Price $7.02 (-0.99%), Market cap $0.07B, 52-week low–high $5.09 ~ $13.98.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a
Financial statements, price targets, institutional (13F) holdings and related news for LENSAR Inc are updated in real time on BlackAll Trade.
LENSAR Inc trades at $7.02 (-0.99%). Real-time quotes and charts are available on BlackAll Trade.
LENSAR Inc has a market cap of about $0.07B.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically i